Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uridine Supplementation in HIV
NCT00471614Phase 2Completed
- Sponsor
- National Center for Complementary and Integrative Health
- Start
- Apr 2007
- Primary completion
- Jan 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of uridine triacetate in mitochondrial toxicity, insulin resistance (IR), sponsored by National Center for Complementary and Integrative Health. Started Apr 2007; status: completed.
02
Drugs
uridine triacetate
03
Conditions
mitochondrial toxicityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT00471614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471614.